BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership73,530 shares
Latest Disclosed Value $ 790,447
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of BCRX / BioCryst Pharmaceuticals, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 73,530 shares of BioCryst Pharmaceuticals, Inc. (US:BCRX) valued at $790,448 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 73,170 shares of BioCryst Pharmaceuticals, Inc.. This represents a change in shares of 0.49% during the quarter. The current value of the position is $618,387 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 73,530 360 0.49 790 25.60 0.0104
2025-04-25 2025-02-28 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 73,170 1,944 2.73 630 17.79 0.0085
2025-01-27 2024-11-30 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 71,226 504 0.71 534 -13.03 0.0072
2024-10-29 2024-08-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 70,722 18,291 34.89 615 41.80 0.0091
2023-07-26 2023-05-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 52,431 168 0.32 434 -6.28 0.0094
2023-04-27 2023-02-28 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 52,263 1,260 2.47 463 -32.16 0.0113
2023-01-26 2022-11-30 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 51,003 1,316 2.65 681 -1.30 0.0170
2022-10-26 2022-08-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 49,687 1,876 3.92 691 55.06 0.0173
2022-07-29 2022-05-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 47,811 1,456 3.14 445 -42.13 0.0113
2022-04-28 2022-02-28 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 46,355 728 1.60 770 39.82 0.0178
2022-01-25 2021-11-30 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 45,627 1,204 2.71 550 -22.21 0.0115
2021-10-26 2021-08-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 44,423 924 2.12 707 3.21 0.0155
2021-07-22 2021-05-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 43,499 -12,465 -22.27 686 195.26 0.0171
2020-10-16 2020-08-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 55,964 1,027 1.87 232 -5.69 0.0072
2020-07-20 2020-05-31 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 54,937 -39,207 -41.65 247 -12.77 0.0096
2020-04-24 2020-02-29 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 94,144 84,262 852.68 282 907.14 0.0126
2020-01-16 2019-11-30 NP BIOCRYST PHARMACEUTICALS EC US09058V1035 9,882 9,882 28 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.